Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-23-037731

Options or other derivatives

  • Director bought 19,311 shares at $2.86 ($55,268)
  • Director acquired 0 shares (option exercise)
  • Director acquired 18,888 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · Director

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-03 Purchase : show line 1 in the form Series D-1 Convertible Preferred Stock +19,311 $2.86 $55,268 690,800 D
2023-10-14 Exercise or conversion : show line 2 in the form 8% Unsecured Convertible Promissory Note −0 D
2023-10-14 Exercise or conversion : show line 3 in the form Series D-1 Convertible Preferred Stock +18,888 709,688 D
Loading xslF345X05/ownership.xml…